Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis
Objective This study aimed to assess the overall economic impact of clinical pharmacist interventions in the neonatal ICU (NICU) in Qatar. Methods A retrospective review of neonates’ records was performed over a 3-month duration in the NICU of Qatar to determine the total economic benefit of clinica...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/20523211.2023.2291508 |
| _version_ | 1797366036749615104 |
|---|---|
| author | Ola Yakti Daoud Al-Badriyeh Mohammed Rijims Mohammed Abdelaal Omar Alsoukhni Moza Al Hail Palli Valapila Abdulrouf Wessam El-Kassem Fouad Abounahia Rasha Kaddoura Dina Abushanab |
| author_facet | Ola Yakti Daoud Al-Badriyeh Mohammed Rijims Mohammed Abdelaal Omar Alsoukhni Moza Al Hail Palli Valapila Abdulrouf Wessam El-Kassem Fouad Abounahia Rasha Kaddoura Dina Abushanab |
| author_sort | Ola Yakti |
| collection | DOAJ |
| description | Objective This study aimed to assess the overall economic impact of clinical pharmacist interventions in the neonatal ICU (NICU) in Qatar. Methods A retrospective review of neonates’ records was performed over a 3-month duration in the NICU of Qatar to determine the total economic benefit of clinical pharmacist interventions. The total benefit of interventions was calculated by considering the cost avoidance due to preventable adverse drug events (ADEs) and the cost savings associated with the revised resource use due to interventions. Sensitivity analyses were conducted to ensure the robustness and generalizability of the results. Results A total of 513 interventions were analyzed, involving 150 neonates. Most of the drug-related problems were related to therapy dosing, followed by drug choice appropriateness, the addition of prophylactic treatment, and administration frequency. The overall annual benefit was estimated at QAR 4,178,352 (1,147,584), which consisted of cost avoidance of QAR 1,050,680 (USD 288,648) and an overall cost saving of QAR −6091 (USD −1673). Conclusions While the clinical pharmacist interventions led to increased resource utilisation and associated costs, when considering the avoided costs of ADEs, the overall clinical pharmacist practices in the NICU setting were economically beneficial. |
| first_indexed | 2024-03-08T16:58:29Z |
| format | Article |
| id | doaj.art-0659a685f186447c892332920dce355d |
| institution | Directory Open Access Journal |
| issn | 2052-3211 |
| language | English |
| last_indexed | 2024-03-08T16:58:29Z |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Pharmaceutical Policy and Practice |
| spelling | doaj.art-0659a685f186447c892332920dce355d2024-01-04T15:59:09ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112024-12-0117117019010.1080/20523211.2023.22915082291508Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysisOla Yakti0Daoud Al-Badriyeh1Mohammed Rijims2Mohammed Abdelaal3Omar Alsoukhni4Moza Al Hail5Palli Valapila Abdulrouf6Wessam El-Kassem7Fouad Abounahia8Rasha Kaddoura9Dina Abushanab10Hamad General HospitalQatar UniversityHamad Medical CorporationMinistry of Public HealthAl Jalila Children's Specialty HospitalHamad Medical CorporationHamad Medical CorporationHamad Medical CorporationHamad Medical CorporationHamad Medical CorporationHamad Medical CorporationObjective This study aimed to assess the overall economic impact of clinical pharmacist interventions in the neonatal ICU (NICU) in Qatar. Methods A retrospective review of neonates’ records was performed over a 3-month duration in the NICU of Qatar to determine the total economic benefit of clinical pharmacist interventions. The total benefit of interventions was calculated by considering the cost avoidance due to preventable adverse drug events (ADEs) and the cost savings associated with the revised resource use due to interventions. Sensitivity analyses were conducted to ensure the robustness and generalizability of the results. Results A total of 513 interventions were analyzed, involving 150 neonates. Most of the drug-related problems were related to therapy dosing, followed by drug choice appropriateness, the addition of prophylactic treatment, and administration frequency. The overall annual benefit was estimated at QAR 4,178,352 (1,147,584), which consisted of cost avoidance of QAR 1,050,680 (USD 288,648) and an overall cost saving of QAR −6091 (USD −1673). Conclusions While the clinical pharmacist interventions led to increased resource utilisation and associated costs, when considering the avoided costs of ADEs, the overall clinical pharmacist practices in the NICU setting were economically beneficial.http://dx.doi.org/10.1080/20523211.2023.2291508adverse drug eventneonatescost savingseconomicsinterventionpharmacist |
| spellingShingle | Ola Yakti Daoud Al-Badriyeh Mohammed Rijims Mohammed Abdelaal Omar Alsoukhni Moza Al Hail Palli Valapila Abdulrouf Wessam El-Kassem Fouad Abounahia Rasha Kaddoura Dina Abushanab Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis Journal of Pharmaceutical Policy and Practice adverse drug event neonates cost savings economics intervention pharmacist |
| title | Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis |
| title_full | Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis |
| title_fullStr | Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis |
| title_full_unstemmed | Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis |
| title_short | Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis |
| title_sort | clinical pharmacists interventions for preventing adverse events in critically ill neonates in qatar an economic impact analysis |
| topic | adverse drug event neonates cost savings economics intervention pharmacist |
| url | http://dx.doi.org/10.1080/20523211.2023.2291508 |
| work_keys_str_mv | AT olayakti clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT daoudalbadriyeh clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT mohammedrijims clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT mohammedabdelaal clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT omaralsoukhni clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT mozaalhail clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT pallivalapilaabdulrouf clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT wessamelkassem clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT fouadabounahia clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT rashakaddoura clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis AT dinaabushanab clinicalpharmacistsinterventionsforpreventingadverseeventsincriticallyillneonatesinqataraneconomicimpactanalysis |